Skip to content

For product queries: Call 1-858-265-6446 or email at info@gentarget.com

| Login / Register | 0 items | $0.00

gentarget inc.

7930 Arjons Drive, Suite B
San Diego, CA 92126
United States

  • Home
  • Products
    • Premade Lentivirus
      • cDNA (ORF) Expression
      • Luciferases Lentivirus
      • Fluorescent Markers
      • Sub-cellular Imaging
      • Nano-Lantern Imaging
      • Cytoskeleton Imaging
      • Unstable GFP
      • near-infrared RFP
      • Fluorescent fusion
      • CRE recombinase
      • LoxP GFP/RFP ColorSwtich
      • SEAP Reporter
      • Tet Repressor
      • rtTA Expression
      • lacZ Enzyme
      • iPS stem cell factors
      • Other enzyme
    • Pathway Reporter
      • Androgen Pathway
      • Antioxidant Pathway
      • C/EBP Pathway
      • CD44CR1 Pathway
      • CREB (cAMP-PKA) Pathway
      • EGR1 Promoter Pathway
      • Estrogen Receptor Pathway
      • Glucocorticoid Pathway
      • Hedgehog Pathway
      • Hypoxia Pathway
      • JAK-STAT Pathway
      • JNK / AP1 Pathway
      • MAPK/ERK Pathway
      • Notch Signal Pathway
      • NFκB Pathway
      • TP53 Pathway
      • Wnt Signal pathway
      • Blue light inducible reporter
      • Heat inducible expression
      • Mitochondrial pH-sensitive probe
      • Signal Pathway Control
    • Cell Immortalization
      • hTERT Expression
      • SV40 Large T antigen
      • P53 siRNA Lentivirus
      • Other Immortalization Factors
    • ImmunoOncology Research
      • CAR-T and More
      • Assay Cell Lines
      • Cell Antigens & Receptors
    • CRISPR Gene Editing
      • Cas9 Expression
      • Epigenomic: CRISPRi and CRISPRa
      • gRNA Lentivirus
      • CRISPR Repair & KnockIn
      • CRISPR KnockOut
    • Stable cell lines
      • Pathway Cell Line
      • Luciferase cells
      • Fluorescent cells
      • CRE reporting cells
      • CRE Expression Cells
      • CRISPR ready cell lines
      • TetR stable cells
      • rtTA stable cells
      • Inducible expression cell lines
      • Ion Channel cells
      • LacZ stable cells
      • Other stable cells
    • Cell-Specific Reporter
      • Astrocytes Report
      • B-Cell Reporter
      • Brain Cell Report
      • Cancer Specific Report
      • Endothelial Cell Report
      • Hematopoietic Cell Report
      • Hepatoma Cell Report
      • Kidney Cell Report
      • Leukocytes Report
      • Lung Tissue Report
      • Macrophages Report
      • Megakaryocytes Report
      • Monocytes Report
      • Muscle Cell Report
      • Neuron Report
      • Ovarian Cancer Report
      • Pancreatic Cancer Report
      • Prostate Cell Report
      • Stem Cell Report
    • Infectious Antigens
      • Viral Antigens
    • Virus Like Particles (VLP)
    • Non-integrating LV
    • Adenovirus
      • Common Markers & Enzymes
      • GFP CFP YFP RFP BFP & Controls
      • iPS Stem Cell Factors
      • ORF Expression
    • shRNA lentivirus
      • Validated shRNA Lentivirus
      • Customized shRNA
    • microRNA lentivirus
    • anti miRNA lentivirus
    • Lentivectors
      • CRISPR gRNA lentivectors
      • shRNA Lentivectors
      • Promoter-less Lentivectors
      • Lentivirus Packaging plasmids
    • Control lentivirus
    • Ultra titer lentivirus
    • Eco PCR Cloning Kits
    • Reagents for Lentivirus
  • Services
    • Lentivirus Service
    • Customized Stable Cell Lines
    • Fusion In Vivo PCR Cloning
    • Protein Expression
    • Antibody Cloning and Expression
  • Support
    • Technology
      • Optional Inducible Lentiviral System
      • SureTiter™ Lentiviral System
      • Enhanced super CMV promoter
      • InTag™ trans-membrane proteins
      • Fusion in vivo, Eco™ PCR Cloning
    • Protocols
    • MSDS Files
    • Promotion
    • Product Manuals
    • Vector sequences
    • Product FAQs
    • Product citations
    • Terms
    • Useful Links
  • Distributors
  • About Us
  • Contact
  • News
Home / ImmunoOncology Research

ImmunoOncology Research

virus ball

GenTarget’s Products for ImmunoOncology / Immunotherapy Research:

Gentarget is dedicated to support the ImmunoOncology or Immunotherapy research field, by providing comprehensive product lines, see product categories listed below. All products are provided for Research Use Only.

  1. Targeted CAR, TCR, TAC lentivirus;
  2. Premade Assay Cell Lines for T-cell targeted killing assay and other cell-based assays;
  3. Premade over-expression lentivirus products for the immune response targets; Cell surface antigens (CDs); immune checkpoint / Receptors;
  4. CRISPR gene Repair and knock-IN lentivirus;
  5. CRISPR knockout lentivirus;

What is Immunotherapy:

Immunotherapy is an emerging cancer treatment roughly including two aspects: (1) deliver the genetically modified T cells to patients to kill cancer cells; (2) promote the immune responses for cancer suppression.

The advantages of Immunotherapy are: (1) the targeted cancer cell treatment can be achieved because of immune system precision. (2) immunotherapy is live, continuous, and dynamical treatment and memorized so it can be self-adjusted, long-term treatment corresponding to the cancer development;(3) T- cell therapy can kill solid tumors, which are difficult to treat with other immune therapies.

How immunotherapy works:

Human immune system is activated when any “foreign substances” are encountered.  The immune response attacks and destroys anything containing Foreign substances, like cancer cells. The principle of immunotherapy is:

  1. activating, training, or engineering patient’s immune cells in a lab and reintroducing them into the same patient, to find and attack cancer cells;
  2. Stimulating, or boosting the natural defenses of your immune system so it works harder or smarter to find and attack cancer cells;

The main types of immunotherapy:

  1. checkpoint inhibitors: Immune checkpoints are molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells sometimes find ways to use these checkpoints to avoid being attacked by the immune system. Checkpoint inhibitors are drugs or antibodies to block the signaling pathway that suppresses the immune system, which enables immune effector cells to attack cancer cells more aggressively. It acts at the activation of immune response, not directly on cancer cells.
  2. Genetically Engineered T Cells: Thistreatmentis directly act on cancer cells including several methods:(1) Expressing a CAR (Chimeric Antigen Receptor) that is composed of an intracellular signaling domain and the linked extracellular domain derived from a tumor-specific antibody. The tumor-specific receptor guilds the T cells to attack specific tumor types. The killing depends upon the desired signaling pathway. The ideal cases are the CAR target only present on tumor cells, not normal cells; (2)The T cell was modified at its endogenous TCR (T Cell Receptor ) gene to recognize a tumor-specific antigen, which activates the native T cell killing signal pathway. The TCR method has less side-effects than CAR does who elevates an un-nature signal level resulted in the severe Cytokine release syndrome side-effect; (3)coupled with a tumor-specific antigen binding domain (TAC: T-cell Antigen Coupler),(4)combined engineered T cells with the knockout of endogenous TCR with insertion of an anti-cancer factor so that the T cell can provide as the allogeneic  adoptive anti-cancer treatment;
  3. Cytokines: Cytokines encompass a variety of protein families including interleukins, interferons, growth factors, tumor necrosis factors, and colony-stimulating factors. Cytokines act on every phase of the cancer immunity cycle, improving antigen priming, inflammation and hematopoiesis, and other specific physiological response to external stimuli including cancer. cytokines can stimulate the immune cells to attack cancer.
  4. Others: cancer immunotherapy has many other types of treatment, including Monoclonal antibodies (raised from cancel specific antigen, attack a very specific part of cancer cell); Cancer vaccines; Oncolytic virus, enrich or enhance the NK cell, Macrophage cell and so on.
NameSKUPriceBuy
A549 / Luciferase-2A-GFP (Puromycin) stable cellsSC043-LG$1,500.00
Anti-CD19-ScFv-4-1BB-CD3ζLVP1444$650.00
Anti-CD19-ScFv-4-1BB-CD3ζ (Bsd)LVP1441$650.00
Anti-CD19-ScFv-4-1BB-CD3ζ (GFP-Puro)LVP1442$650.00
Anti-CD19-ScFv-4-1BB-CD3ζ (Puro)LVP1440$650.00
Anti-CD19-ScFv-4-1BB-CD3ζ (RFP-Puro)LVP1443$650.00
Anti-CD19-ScFv-CD28-CD3ζLVP1449$650.00
Anti-CD19-ScFv-CD28-CD3ζ (Bsd)LVP1446$650.00
Anti-CD19-ScFv-CD28-CD3ζ (GFP-Puro)LVP1447$650.00
Anti-CD19-ScFv-CD28-CD3ζ (Puro)LVP1445$650.00
Anti-CD19-ScFv-CD28-CD3ζ (RFP-Puro)LVP1448$650.00
CAR negative control: 4-1BB-CD3ζCAR-Ctr1$395.00
CAR negative control: Anti-CD19-ScFv-4-1BBCAR-Ctr2$395.00
CAR negative control: Anti-CD19-ScFv-CD28CAR-Ctr4$395.00
CAR negative control: CD28-CD3ζCAR-Ctr3$395.00
CHO / CD19 & GFP Expression Stable Cell LineSC086$4,000.00
CHO-GFP stable cells (Puromycin)SC039-Puro$700.00
GFP & RFP HEK293 stable cellsSC009$1,400.00
h CD19 (EF1a, Puro) Expression, Concentrated LentivirusLVP1451$650.00
h CD26 (EF1a, Puro) Expression, Concentrated LentivirusLVP1452$650.00
h PDL1 (EF1a, Puro) Expression, Concentrated LentivirusLVP1450$650.00
HEK293 / h PDL1 Expression Stable CellsSC083$1,500.00
HEK293 / human CD19 Expression Stable Cell LineSC087$3,000.00
Hela-GFP stable cells (Bsd)SC034-Bsd$650.00
Hela-nucGFP stable cellsSC070-G$1,000.00
Human 786-O (Luciferase / GFP) Stable CellsSC069-LG$3,500.00
Human AsPC1 (Luciferase & GFP) Stable CellsSC062-LG$1,500.00
Human B lymphocyte / GFP Stable CellsSC060-G$2,000.00
Human ES2 (Luciferase & GFP) Stable CellsSC066-LG$1,500.00
Human HT-29 / GFP Stable CellsSC080-G$2,500.00
Human MCF10A / GFP (Puro) Stable CellsSC073-GP$2,500.00
Human PANC-1 / (Luciferase & GFP) Stable CellsSC068-LG$2,000.00
Human SH-SY5Y / GFP stable cell lineSC042$550.00
Human SH-SY5Y / Luciferase (firefly) stable cell lineSC094-Luc$1,500.00
Human SW1990 / GFP (Puro) Stable CellsSC074-GP$2,000.00
Human SW403 / GFP Stable CellsSC067-G$1,000.00
Human T47D / GFP Stable CellsSC072-G$1,500.00
Human U2OS / GFP Stable CellsSC084-G$2,500.00
Jurkat / GFP stable Cell Line (EF1a Promoter)SC049-1$2,000.00
Luciferase & GFP / HEK293 stable cells (Puro)SC002-GP$600.00
MDA-MB-231 / GFP (Puro) stable cell lineSC040-Puro$800.00
MLLB2 / GFP (Neomycin) stable cell lineSC055-G$1,000.00
Mouse CT26 / GFP Stable CellsSC061-G$1,000.00
Mouse CT26 / PDL1 Stable CellsSC061-PDL1$1,500.00
Mouse MB49 (Luciferase & GFP) Stable CellsSC065-LG$2,000.00
Mouse MB49 / GFP Stable CellsSC065-G$1,500.00
Mouse Panc02 / GFP Stable Cell LineSC078-G$3,000.00
RKO / GFP stable cells (Blasticidin)SC047-GB$800.00

    Cart

    Product Selection Guides

    • Luciferase Imaging
    • Fluorescent Markers
    • Sub-cellular Imaging
    • Signal Pathway Assay
    • CRISPR Gene Editing
    • ImmunoOncology Research
    • Cell Immortalization
    • Inducible Expression
    • Reporter Cell Lines
    • Promoter Research
    • iPS Factors

    VIEW MORE

    Stay Connected

    Online Payment Service
  • Home
  • Products
    • Premade Lentivirus
    • Pathway Reporter
    • Cell Immortalization
    • ImmunoOncology Research
    • CRISPR Gene Editing
    • Stable cell lines
    • Cell-Specific Reporter
    • Infectious Antigens
    • Virus Like Particles (VLP)
    • Non-integrating LV
    • Adenovirus
    • shRNA lentivirus
    • microRNA lentivirus
    • anti miRNA lentivirus
    • Lentivectors
    • Control lentivirus
    • Ultra titer lentivirus
    • Eco PCR Cloning Kits
    • Reagents for Lentivirus
  • Services
    • Lentivirus Service
    • Customized Stable Cell Lines
    • Fusion In Vivo PCR Cloning
    • Protein Expression
    • Antibody Cloning and Expression
  • Support
    • Technology
    • Protocols
    • MSDS Files
    • Promotion
    • Product Manuals
    • Vector sequences
    • Product FAQs
    • Product citations
    • Terms
    • Useful Links
  • Distributors
  • About Us
  • Contact
  • News

2008 ~ ©, 2023 GenTarget Inc. All rights reserved.

Contact | Terms | View Cart

Scroll Up